Jennifer Herington Archive — Page 1 of 1

September 23, 2026

Vanderbilt Health study identifies drugs with potential to improve outcomes associated with preterm labor

The findings do not mean that these drugs are ready to be used clinically for preterm labor; rather, they identify promising candidates for further development.

Jennifer Herington, PhD, and Todd Giorgio, PhD, during their in-person visit to ARPA-H in July.
November 14, 2024

VUMC receives $3.3 million ARPA-H award to develop at-home therapy for preterm labor

This project will be the first to apply drug conjugates in the field of obstetrics.

February 9, 2016

Therapies to prevent preterm birth

Vanderbilt researchers have developed a high-throughput assay that will aid in identifying new compounds to treat preterm labor or postpartum bleeding.